More than 15 years ago, scientists at the University of Missouri’s Research Reactor (MURR) identified promising properties of the radioisotope lutetium-177 (Lu-177), which can be used to treat cancer. It was recently announced that the U.S. Food and Drug Administration has approved a Lu-177 based drug, Lutathera (lutetium Lu 177 dotatate), to treat certain types of…
Promising New Drug Development Could Help Treat Cachexia
New Imaging Technique Shows Effectiveness of Cystic Fibrosis Drug
Man-Made Materials with the Potential to Revolutionize Cancer Therapies & Drug Delivery
Natural Compound Could Improve Treatment of Triple-Negative Breast Cancer
New Drug Could Help Prevent Artery Disease in High-Risk Patients
Anti-TB Drug Disrupted by Botanical Supplement, Can Lead to Development of Disease
Botanical supplements are used by people around the world to treat a wide range of physical and mental ailments. Some of these botanical supplements have high levels of antioxidants, which may have some positive health effects for certain conditions. However, a new study from the University of Missouri in partnership with scientists in Africa has uncovered evidence…